Manulife (Manufacturers Life Insurance)’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.49M Sell
59,527
-4,694
-7% -$132K ﹤0.01% 1622
2025
Q4
$2.02M Sell
64,221
-8,676
-12% -$288K ﹤0.01% 1514
2025
Q3
$2.6M Sell
72,897
-22,405
-24% -$1.02M ﹤0.01% 1419
2025
Q2
$5.49M Buy
95,302
+23,049
+32% +$1.3M ﹤0.01% 1122
2025
Q1
$4.21M Buy
72,253
+6,433
+10% +$439K ﹤0.01% 1237
2024
Q4
$5.3M Buy
65,820
+6,785
+11% +$580K ﹤0.01% 1179
2024
Q3
$4.73M Sell
59,035
-3,527
-6% -$251K ﹤0.01% 1236
2024
Q2
$3.82M Sell
62,562
-10,469
-14% -$623K ﹤0.01% 1278
2024
Q1
$3.61M Buy
73,031
+2,665
+4% +$127K ﹤0.01% 1314
2023
Q4
$2.95M Sell
70,366
-12,590
-15% -$429K ﹤0.01% 1348
2023
Q3
$2.72M Buy
82,956
+14,088
+20% +$480K ﹤0.01% 1342
2023
Q2
$2.43M Buy
68,868
+8,729
+15% +$289K ﹤0.01% 1351
2023
Q1
$1.71M Buy
60,139
+5,367
+10% +$189K ﹤0.01% 1441
2022
Q4
$2.25M Buy
54,772
+260
+0.5% +$11.2K ﹤0.01% 1351
2022
Q3
$2.22M Sell
54,512
-14,349
-21% -$572K ﹤0.01% 1357
2022
Q2
$2.21M Buy
68,861
+12,694
+23% +$462K ﹤0.01% 1397
2022
Q1
$1.95M Buy
+56,167
New +$1.35M ﹤0.01% 1515

Other funds holding PRCT